Skip to main content

Rheumatoid Arthritis and cannabis in Massachusetts

The state explicitly lists this condition under its medical cannabis program. A certifying physician can pursue state registration for a patient with this diagnosis under the program rules.

Listed qualifying condition
✓ Yes
LEGAL
10 oz usable (60-day su…
POSSESSION
$50/yr
STATE FEE
7–21 d
TIMELINE
Listed qualifying condition. The state explicitly lists this condition under its medical cannabis program. A certifying physician can pursue state registration for a patient with this diagnosis under the program rules.

Massachusetts statute and program

The Massachusetts Medical Use of Marijuana Program is the operating authority for Massachusetts patient certification. The authoritative legal text is: M.G.L. Chapter 94G: Regulation of the Use and Distribution of Marijuana Not Medically Prescribed. The program portal is at Massachusetts Medical Use of Marijuana Program.

What the evidence says about cannabis and Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease in which the body's immune system attacks the synovium (the membrane lining the joints), causing inflammation, pain, swelling, stiffness, and progressive joint damage. RA typically affects the small joints of the hands and feet symmetrically, often with morning stiffness lasting more than an hour. Untreated, RA can cause permanent joint deformity, bone erosion, and significant disability. Extra-articular manifestations include rheumatoid nodules, interstitial lung disease, vasculitis, and accelerated cardiovascular disease.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Rheumatoid Arthritis page.

How to qualify in Massachusetts

The Massachusetts Medical Use of Marijuana Program requires the following registration steps for a Rheumatoid Arthritis patient (or any qualifying diagnosis):

  1. Get certified by a Massachusetts-licensed certifying healthcare provider. A Massachusetts-licensed physician, certified nurse practitioner, or physician assistant registered with the Cannabis Control Commission (CCC) Medical Use of Marijuana Program must establish a bona-fide provider-patient relationship and certify a debilitating condition. CCC regulations allow providers to certify enumerated conditions (cancer, glaucoma, HIV/AIDS, hepatitis C, ALS, Crohn’s, Parkinson’s, MS) plus "other conditions determined by a qualifying provider" — broad practitioner discretion.
  2. Complete the online patient registration via Virtual Gateway. After certification, the provider creates a Virtual Gateway PIN that the patient uses to complete the online registration through the Massachusetts Cannabis Control Commission MMJ Online System. Patients upload a Massachusetts driver license or state ID and a passport-style photo.
  3. Pay the $50 state fee (or qualify for fee waiver). The annual program registration fee is $50, waived for veterans, low-income patients (verified through MassHealth, SNAP, SSI, SSDI, or Veterans Affairs benefits documentation), and hospice patients. Temporary patient registration cards are emailed within several business days of approval; physical cards arrive within roughly two to three weeks.
  4. Purchase from a Massachusetts medical marijuana treatment center. With the temporary or physical card, patients may purchase up to a 60-day supply (default 10 ounces) from any of the licensed Massachusetts Medical Marijuana Treatment Centers. Adult-use retail exists statewide for adults 21+, but the medical registration provides access to medical-only products, no excise tax, higher possession limits, and family-court and workplace protections under M.G.L. c. 94I.
State registration fee
$50
Physician visit (typical)
$150–$300
Certification to card
7–21 days
Out-of-state patients
Not eligible
Minors
Eligible with caregiver

For full Massachusetts registration steps, fees, and reciprocity rules, see the Massachusetts cannabis-laws page.

ICD-10 code

A certifying physician documenting Rheumatoid Arthritis for the Massachusetts medical cannabis program will typically record ICD-10 M06.9 or SNOMED-CT 69896004 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does Massachusetts list Rheumatoid Arthritis as a qualifying condition for medical cannabis?

Yes. Massachusetts explicitly lists Rheumatoid Arthritis as a qualifying condition under Massachusetts Medical Use of Marijuana Program. A patient with a documented Rheumatoid Arthritis diagnosis can pursue state-program certification with a physician registered in the state. The qualifying-condition list is published by the state at https://masscannabiscontrol.com/medical-use/ and may change as regulators add, remove, or refine entries. Inclusion on the list does not guarantee certification — a physician still has to evaluate the patient and decide that medical cannabis is appropriate for that specific case under Massachusetts rules.

How do I get a Massachusetts medical marijuana card for Rheumatoid Arthritis?

Step one is finding a physician licensed in Massachusetts who is registered with Massachusetts Medical Use of Marijuana Program and willing to evaluate Rheumatoid Arthritis cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Massachusetts does not honor out-of-state cards, so the certification process has to originate inside the state. Verify the patient minimum age with the state program before applying. The authoritative source for the current process is the Massachusetts Medical Use of Marijuana Program site at https://masscannabiscontrol.com/medical-use/; the state updates fees, forms, and physician registration rules periodically.

What does the evidence say about cannabis for Rheumatoid Arthritis?

For Rheumatoid Arthritis, evidence is described as limited (a small number of supportive studies, often underpowered or focused on narrow symptom domains). The mmjnow condition page for Rheumatoid Arthritis lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Rheumatoid Arthritis should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Rheumatoid Arthritis and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Rheumatoid Arthritis; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. M.G.L. Chapter 94G: Regulation of the Use and Distribution of Marijuana Not Medically Prescribedaccessed May 16, 2026
  2. M.G.L. Chapter 94I: Medical Use of Marijuanaaccessed May 16, 2026
  3. Massachusetts Cannabis Control Commissionaccessed May 16, 2026
  4. Question 4 of 2016: Regulation and Taxation of Marijuana Act (Ballotpedia)accessed May 16, 2026
  5. NORML: Massachusetts Laws & Penaltiesaccessed May 16, 2026
  6. NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 16, 2026
  7. American College of Rheumatology: Cannabis & Rheumatic Diseasesaccessed May 16, 2026